Subsidy Tracker Parent Company Summary

Parent Company Name: 
AstraZeneca
Ownership Structure: 
publicly traded (ticker symbol AZN)
Headquartered in: 
Britain
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$315,582,90433
Federal (grants and allocated tax credits)$11,758,3666
TOTAL$327,341,27039
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 1996. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

AMYLIN; ASTRAZENECA; MEDIMMUNE

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
Delaware$178,135,4499
Ohio$117,000,0006
Maryland$20,447,45518

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
AstraZeneca Delaware multiple 1999 $178,000,000 MEGADEAL
Amylin Pharmaceuticals Ohio multiple 2007 $117,000,000 MEGADEAL
MedImmune Inc. Maryland state 2006 $7,500,000 grant/loan hybrid program
MEDIMMUNE, LLC United States federal 2017 $4,864,964 federal grant
AstraZeneca Pharmaceuticals LP United States federal 2012 $2,713,491 federal grant
MEDIMMUNE, LLC United States federal 2018 $2,383,754 federal grant
Medimmune, Inc. Maryland state 2007 $1,570,977 tax credit/rebate
MedImmune, LLC Maryland state 2016 $1,553,113 tax credit/rebate
MedImmune LLC Maryland state 2015 $1,500,000 grant/loan hybrid program
Medimmune, LLC Maryland state 2012 $1,497,096 tax credit/rebate
Medimmune, LLC Maryland state 2014 $1,497,096 tax credit/rebate
MEDIMMUNE, LLC United States federal 2018 $1,324,736 federal grant
Medimmune, LLC Maryland state 2015 $1,264,635 tax credit/rebate
Medimmune, Inc. Maryland state 2005 $728,623 tax credit/rebate
Medimmune, LLC Maryland state 2010 $698,034 tax credit/rebate
Medimmune, LLC Maryland state 2008 $611,575 tax credit/rebate
MedImmune, Inc. Maryland local $500,000 grant/loan hybrid program
Medimmune, LLC Maryland state 2009 $490,223 tax credit/rebate
Medimmune, LLC Maryland state 2011 $462,285 tax credit/rebate
AMYLIN OHIO LLC Ohio state 2009 $414,661 grant
MEDIMMUNE VACCINES INC United States federal 2002 $323,750 federal grant
Medimmune, Inc. Maryland state 2004 $294,900 tax credit/rebate
AMYLIN OHIO LLC Ohio state 2013 $150,000 grant
MEDIMMUNE VACCINES INC United States federal 2002 $147,671 federal grant
AMYLIN OHIO LLC Ohio state 2010 $138,219 grant
Medimmune Oncology, Inc. Maryland state 2005 $111,606 tax credit/rebate
Medimmune Oncology, Inc. Maryland state 2004 $103,579 tax credit/rebate
Astra Zeneca Pharmaceutical Delaware state 2010 $47,404 training reimbursement
AMYLIN OHIO LLC Ohio state 2012 $45,000 grant
Medimmune Oncology, Inc. Maryland state 2007 $36,938 tax credit/rebate
AMYLIN OHIO LLC Ohio state 2010 $31,792 grant
MedImmune, Inc. Maryland state 2004 $26,775 training reimbursement
Astra Zeneca Pharmaceutical Delaware state 2012 $20,276 training reimbursement
Astra Zeneca Pharmaceutical Delaware state 2006 $16,820 training reimbursement
Astra Zeneca Pharmaceutical Delaware state 2008 $16,264 training reimbursement
Astra Zeneca Pharmaceutical Delaware state 2005 $14,972 training reimbursement
Astra Zeneca Pharmaceutical Delaware state 2009 $7,195 training reimbursement
Astra Zeneca Pharmaceutical Delaware state 2007 $6,650 training reimbursement
AstraZeneca Pharmaceuticals Delaware state 2016 $5,868 training reimbursement
Download results as CSV or XML